Eli Lilly and Company is a global pharmaceutical company focused on discovering, developing, manufacturing, and marketing prescription medicines for human health. Headquartered in Indianapolis, Indiana, and founded in 1876, the company operates in therapeutic areas that include diabetes, obesity, oncology, immunology, neuroscience, and other specialty conditions. Eli Lilly and Company’s portfolio features innovative treatments for metabolic diseases, cancer, autoimmune disorders, and neurological conditions, supported by a broad pipeline of biologics, small molecules, and next-generation therapies. The company conducts research and clinical development across multiple geographies and manufactures medicines through facilities in the United States, Puerto Rico, Europe, and Asia, distributing its products in around 90 countries. Eli Lilly and Company plays a significant role in the healthcare system by working with physicians, hospitals, payers, and governments to make its therapies available to patients worldwide, while maintaining a single core business segment centered on human pharmaceutical products.